| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277 |
| filingDate |
2001-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2003-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2003534279-A |
| titleOfInvention |
Pharmaceutical combinations of bicalutamide and anastrozole for providing antiandrogenic action and aromatase inhibition |
| abstract |
(57) [Summary]nThe present invention relates to 4'-cyano-α ', α', α'-trifluoro-3- (4-fluorophenylsulfonyl) -2-hydroxy-2-methylpropiono-m-toluidide (compound I) and analogs. It relates to a pharmaceutical product containing anastrozole, a daily dose or a dosage regimen. The invention further relates to a method for providing an anti-androgen effect and aromatase inhibition to a patient, wherein the method provides aromatase inhibition with little additional increase in circulating androgen levels. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265328-B2 |
| priorityDate |
2000-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |